Company intelligence / Profile preview

Biotis Pharmaceuticals Indonesia

Unspecified, Jawa Barat, Indonesiapharmaservicesdirectory.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

PT Biotis Pharmaceutical is an Indonesian biotechnology company specializing in the discovery, development, manufacture, and commercialization of high-quality vaccines—primarily serving the animal production industry. The company employs advanced technologies for sustainable biotechnology solutions that meet international quality standards.

Therapeutic areas: Infectious Diseases
Modalities: Vaccines (biological-based products)Likely other biologics for animal health and possibly human health
Industry: Veterinary

Drug pipeline

3 assets

INAVAC

Commercial

Indications: COVID-19

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Biotis Pharmaceuticals Indonesia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biotis Pharmaceuticals Indonesia.

Explore the full profile